Latest Breaking News On - Oyagen inc - Page 3 : comparemela.com

Tonix Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Highlights

Tonix Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Highlights
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United statesNew bedfordJon mitchellMike kennealyJessica morrisSeth ledermanOlipriya dasCarolyne taylorPeter vozzoTonix pharmaceuticalsDrug administrationHarvard medical schoolData monitoring committeeDevelopment centerEconomic developmentExchange commission

AREV Expands Operations to Rochester New York Establishing

AREV Expands Operations to Rochester New York Establishing
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomDistrict of columbiaRochester institute of technologyUniversity of rochesterBritish columbiaHarold smithDenby greensladeChads johnsonKevinj phelpsMichael withrowMike withrowHarvard law schoolAmerican bioextracts incOyagen inc

TNXP: Interim Analysis for Phase 3 RALLY Trial in 3Q21; Topline Results in 1Q22…

By David Bautz, PhD NASDAQ:TNXP READ THE FULL TNXP RESEARCH REPORT Business Update Tonix Pharmaceutical Holdings Corp. (NASDAQ:TNXP) has undergone a transformation over the past year as it has built up a robust pipeline of clinical stage assets focused on the treatment of central nervous system (CNS) and immunological diseases. In addition, the company’s balance sheet has never been stronger. As of March 31, 2021, Tonix had approximately $164.2.

New zealandUnited statesDavid bautzInfectious diseases integrated research facilityNational cancer instituteNational institutes of allergyReckitt benckiser pharmaceuticalsColumbia universityTrigemina incTonix pharmaceutical holdings corpZacks small cap researchOyagen incPharmaceutical holdingsInterim analysisTopline dataCocaine intoxication

AREV Engages Dr Harold C Smith to Join Scientific

VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV”) is pleased to announce the.

New yorkUnited statesUnited kingdomBritish columbiaUniversity of rochesterHarold smithKevin phelpsHaroldc smithMike withrowConsultants of the companySchool of dentistryNational institutes of allergiesTonix pharmaceutical holdings corpRochester bioventure centerOyagen incNational institutions of health

Tonix Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Highlights

Share: Interim Analysis of Second Confirmatory Phase 3 Study in Fibromyalgia Expected in Third Quarter 2021 Deep Pipeline Progressing with Three Central Nervous System (CNS) Programs Expected to Enter Phase 2 Trials This Year At March 31, 2021, Cash and Cash Equivalents Totaled Approximately $164 Million CHATHAM, N.J., May 10, 2021 (GLOBE NEWSWIRE) Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2021 and provided an overview of recent operational highlights. Tonix possesses a deep pipeline of high-value programs ranging from preclinical to mid-Phase 3 development, with three CNS programs poised to enter Phase 2 trials this year, said Seth Lederman, M.D., President and Chief Executive Officer. Our strategy is to in-license, acquire or internally invent high impact therapeutic programs which we can validate, de-risk and advance

United statesRydyznski moderbacherJessica morrisSeth ledermanOlipriya dasLe bertPeter vozzoUs national cancer instituteTonix pharmaceuticalsFrench national institute of healthHarvard medical school teaching hospital massachusettsDrug administrationExchange commissionTonix pharmaceuticals holding corpOyagen incAnnounced positive efficacy data